Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
Details for Australian Patent Application No. 2004292351 (hide)
International Classifications
Event Publications
18 May 2006 PCT application entered the National Phase
PCT publication WO2005/051404 Priority application(s): WO2005/051404
19 November 2009 Application Accepted
Published as AU-B-2004292351
18 March 2010 Standard Patent Sealed
20 September 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Tasly Pharmaceutical Group Co., Ltd . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser